Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group.
Lange
D J
DJ
Department of Neurology, Baylor College of Medicine, Houston, TX, USA.
Felice
K J
KJ
Festoff
B W
BW
Gawel
M J
MJ
Gelinas
D F
DF
Kratz
R
R
Lai
E C
EC
Murphy
M F
MF
Natter
H M
HM
Norris
F H
FH
Rudnicki
S
S
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D008297:Male
D007334:Insulin-Like Growth Factor I